97 related articles for article (PubMed ID: 11150400)
1. Cardioprotection induced by AT1R blockade after reperfused myocardial infarction: association with regional increase in AT2R, IP3R and PKCepsilon proteins and cGMP.
Jugdutt BI; Xu Y; Balghith M; Moudgil R; Menon V
J Cardiovasc Pharmacol Ther; 2000 Oct; 5(4):301-11. PubMed ID: 11150400
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins.
Xu Y; Menon V; Jugdutt BI
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):184-95. PubMed ID: 11967812
[TBL] [Abstract][Full Text] [Related]
3. Enhanced regional AT(2)-receptor and PKC(epsilon) expression during cardioprotection induced by AT(1)-receptor blockade after reperfused myocardial infarction.
Jugdutt BI; Balghith M
J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):134-40. PubMed ID: 11881113
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor.
Jugdutt BI; Yi Xu ; Balghith M; Menon V
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S162-S166. PubMed ID: 28095238
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of angiotensin II type 2 receptor, inositol 1,4, 5-trisphosphate receptor, and protein kinase cepsilon during cardioprotection induced by angiotensin II type 2 receptor blockade.
Xu Y; Clanachan AS; Jugdutt BI
Hypertension; 2000 Oct; 36(4):506-10. PubMed ID: 11040227
[TBL] [Abstract][Full Text] [Related]
6. AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat.
Jugdutt BI; Menon V
Mol Cell Biochem; 2004 Jul; 262(1-2):203-14. PubMed ID: 15532725
[TBL] [Abstract][Full Text] [Related]
7. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
Jugdutt BI; Menon V
Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
[TBL] [Abstract][Full Text] [Related]
8. Increased AT(2)R protein expression but not increased apoptosis during cardioprotection induced by AT(1)R blockade.
Moudgil R; Musat-Marcu S; Xu Y; Kumar D; Jugdutt BI
Can J Cardiol; 2002 Oct; 18(10):1107-16. PubMed ID: 12420045
[TBL] [Abstract][Full Text] [Related]
9. Increased AT2R protein expression but not increased apoptosis during cardioprotection induced by AT1R blockade.
Moudgil R; Musat-Marcu S; Xu Y; Kumar D; Jugdutt BI
Can J Cardiol; 2002 Aug; 18(8):873-83. PubMed ID: 12215750
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pretreatment with the angiotensin II type 1 receptor blocker UP269-6 and losartan in the dog: effect on hemodynamics and ischemia-reperfusion.
O'Brien DW; Xu Y; Menon V; Jugdutt BI
J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):129-37. PubMed ID: 11150392
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
Jugdutt BI; Menon V
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
[TBL] [Abstract][Full Text] [Related]
12. Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart.
Lange SA; Wolf B; Schober K; Wunderlich C; Marquetant R; Weinbrenner C; Strasser RH
J Cardiovasc Pharmacol; 2007 Jan; 49(1):46-55. PubMed ID: 17261963
[TBL] [Abstract][Full Text] [Related]
13. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction.
Jugdutt BI; Menon V
J Card Fail; 2004 Feb; 10(1):74-82. PubMed ID: 14966778
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin subtype-2 receptor (AT2 ) negatively regulates subtype-1 receptor (AT1 ) in signal transduction pathways in cultured porcine adrenal medullary chromaffin cells.
Ishii K; Takekoshi K; Shibuya S; Kawakami Y; Isobe K; Nakai T
J Hypertens; 2001 Nov; 19(11):1991-9. PubMed ID: 11677364
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blockade with candesartan protects the porcine myocardium from reperfusion-induced injury.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1998 Aug; 32(2):231-8. PubMed ID: 9700985
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion.
Kumar D; Menon V; Ford WR; Clanachan AS; Jugdutt BI
Mol Cell Biochem; 2004 Mar; 258(1-2):211-8. PubMed ID: 15030186
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts.
Kumar D; Menon V; Ford WR; Clanachan AS; Jugdutt BI
J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):285-96. PubMed ID: 14740078
[TBL] [Abstract][Full Text] [Related]
18. Effects of local inhibition of the cardiac renin-angiotensin system with CV-11974 in a canine ischaemia-reperfusion model.
So T; Nakashima Y; Imamura M; Arakawa K
Clin Exp Pharmacol Physiol; 1998; 25(7-8):503-9. PubMed ID: 9673420
[TBL] [Abstract][Full Text] [Related]
19. Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1999 Oct; 34(4):512-7. PubMed ID: 10511125
[TBL] [Abstract][Full Text] [Related]
20. Activation of angiotensin II subtype 2 receptor induces catecholamine release in an extracellular Ca(2+)-dependent manner through a decrease of cyclic guanosine 3',5'-monophosphate production in cultured porcine adrenal medullary chromaffin Cells.
Takekoshi K; Ishii K; Kawakami Y; Isobe K; Nakai T
Endocrinology; 2001 Jul; 142(7):3075-86. PubMed ID: 11416030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
